Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Bruker reported revenue of $797.4 million for the quarter ended June 2025, reflecting a year-over-year decline of 0.4% and an EPS of $0.32 compared to $0.52 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $796.5 million by 0.11%, while the EPS fell short of the consensus estimate of $0.33 by 3.03% [1] Financial Performance Metrics - Organic revenue growth for Bruker was -7%, significantly below the three-analyst average estimate of -1.9% [4] - Bruker Scientific Instruments (BSI) experienced an organic revenue decline of -7.2%, compared to the -2% average estimate from two analysts [4] - Bruker Energy & Supercon Technologies (BEST) reported organic revenue growth of -4.8%, which was better than the -6.8% estimated by two analysts [4] - Revenue eliminations amounted to -$2.1 million, better than the three-analyst average estimate of -$5.88 million, representing a year-over-year change of -47.5% [4] - Revenue for Bruker Energy & Supercon Technologies (BEST) was $66.3 million, slightly below the $67.51 million average estimate from three analysts, marking a year-over-year decline of 4.1% [4] Stock Performance - Bruker's shares have returned -10.5% over the past month, contrasting with the Zacks S&P 500 composite's increase of 0.6% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]